What is LOPJLB’s current signal on FTH?

LOPJLB’s latest quantitative signal on Faeth Therapeutics, Inc. (FTH) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is FTH in?

Faeth Therapeutics, Inc. (FTH) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Faeth Therapeutics, Inc. (FTH) do?

Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]